From Yahoo Finance: 2025-04-27 15:44:00

Pharmaceutical tariffs could soon impact generic drug supply, with warnings that China and India may stop business with the U.S. 90% of U.S. prescriptions are generic. Experts fear shortages and price hikes. Tariffs may worsen existing drug shortages. 250 shortages currently in the U.S., with antibiotics particularly affected.

President Trump plans to impose “major” pharmaceutical tariffs soon, despite initial exemptions. Experts warn of shortages and price spikes for generics. Generic drug companies already struggling with competition and tight margins. 40% of generics have limited ingredient suppliers. Tariffs could worsen supply chain fragility.

Warnings of impending generic drug shortages due to potential pharmaceutical tariffs. Trump administration investigating pharmaceutical imports for national security reasons. Trump claims U.S. must not rely on other countries for drugs in times of conflict. Experts skeptical of administration’s plan, foreseeing increased drug shortages and U.S. dependence on China.

Tariffs on generic drugs could lead to more shortages, increased U.S. reliance on China and delayed Indian investments. India is a major global supplier of generics. Experts doubt that the industry will make major changes as a result of tariffs. Concerns about greater drug shortages and delays in investments in America.

Read more: Experts Warn Tariffs Could Negatively Impact ‘Pretty Fragile Supply’ Of Generic Drugs